secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001493152-25-011630
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack appoints David S. Hirsh, MD as Medical Director, Cardiology
----------------------------------------------------------------------

- Dr. Hirsh, a cardiac electrophysiologist, joins Glucotrack's clinical advisory team for its CBGM program.
- He will oversee clinical and educational initiatives supporting the CBGM's intravascular placement approach.
- Glucotrack is advancing its CBGM through a long-term OUS early feasibility study and upcoming US pilot study.
- CBGM is a long-term implantable system measuring glucose directly from blood, with up to 3-year sensor life.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225011630/0001493152-25-011630-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225011630/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011630

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer